ARG-BPC-157 5 mg

Information:

• The product (substance) isn't a food or diet supplement and is not suitable for human consumption.
• Keep out of children's reach
• Keep container tightly closed.
• Store in a dry, cool and shaded place; protect from moisture.
• Store only in the original container.
• Avoid contact during pregnancy and breast feeding.
• Consult a doctor in the event of feeling unwell or having adverse effects related to the contact with the substance.

The arginate salt of BPC-157 is highly stable in human gastric juice and increases bioavailability after oral administration from less than 3% to over 90%. The arginate salt of BPC-157 is also more stable in environments with varying temperatures and is resistant to UV light exposure. Studies show that only 5% of BPC-157 arginate degrades after 5 hours in gastric acid, compared to 98% degradation of the acetate salt after oral administration. The increased oral bioavailability of the arginate salt makes it the preferred choice in studies on oral BPC-157.
ARG-BPC-157 5 mg utilizes the arginate salt form of BPC-157, which offers exceptional stability and significantly enhanced oral bioavailability. This formulation increases bioavailability from less than 3% with traditional acetate salts to over 90%, making it far more effective when administered orally. The arginate salt demonstrates remarkable resistance to degradation in human gastric juice, with only 5% breakdown after 5 hours in gastric acid, compared to a 98% degradation rate observed with the acetate salt. Additionally, ARG-BPC-157 5 mg maintains stability across varying temperature conditions and resists UV light exposure, ensuring consistent potency and reliability. These properties make the arginate salt the preferred choice in research and therapeutic applications involving oral BPC-157, supporting improved absorption and efficacy in clinical and experimental settings.